HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea · Delayed Price · Currency is KRW 2,420.00
0.00 (0.00%)
At close: Sep 3, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 43.1 billion as of September 4, 2026. Its market cap has decreased by -60.66% in one year.
Market Cap
43.10B
Enterprise Value
43.65B
Revenue
72.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,420.00
ChartMarket Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 43.10B, a decrease of -83.06%. That is a compound annual growth rate of -23.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 43.10B | -64.91% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 271.08B |
| DreamCIS | 83.89B |
| P&K Skin Research Center | 52.77B |
| Kolmar BioTech | 36.86B |
| SLS BIO | 26.89B |
| C&R Research | 22.79B |
| DT&CRO CO. | 19.79B |
| Curachem | 12.65B |